Detalhe da pesquisa
1.
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Nat Immunol;
23(6): 940-946, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35534723
2.
Obstetric and Early Neonatal Outcomes Following Second and Third COVID-19 Vaccination in Pregnancy.
Isr Med Assoc J;
26(1): 12-17, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38420636
3.
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis;
76(7): 1315-1317, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36366729
4.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
J Infect Dis;
225(5): 785-792, 2022 03 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34850049
5.
Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study.
Am J Epidemiol;
191(7): 1224-1234, 2022 06 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35238329
6.
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022.
Euro Surveill;
27(39)2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36177870
7.
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
Euro Surveill;
27(30)2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35904058
8.
Screening for Asymptomatic Urinary Retention in Older Adult Men at Admission to the Internal Medicine Department: A Prospective Study.
Isr Med Assoc J;
23(7): 432-436, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34251126
9.
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
N Engl J Med;
387(22): 2092-2094, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36351266
10.
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
N Engl J Med;
386(14): 1377-1380, 2022 04 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35297591
11.
Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
Rheumatol Int;
40(4): 663-669, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31367795
12.
Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review.
Infect Dis Ther;
12(9): 2223-2240, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37704801
13.
The Use of Rapid COVID-19 Antigen Test in the Emergency Department as a Decision-Support Tool.
Microorganisms;
11(2)2023 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36838249
14.
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.
JAMA Netw Open;
6(5): e2314757, 2023 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37219906
15.
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.
Lancet Microbe;
4(5): e309-e318, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36963419
16.
Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers.
Infect Control Hosp Epidemiol;
43(10): 1433-1438, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34551833
17.
Rapid Antigen Tests For Safe School Opening in the COVID-19 Pandemic Era.
Pediatr Infect Dis J;
41(8): e312-e317, 2022 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35544718
18.
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.
Nat Commun;
13(1): 7711, 2022 12 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36513665
19.
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.
JAMA Netw Open;
5(9): e2231778, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36107426
20.
Real-World Immunogenicity and Reactogenicity of Two Doses of Pfizer-BioNTech COVID-19 Vaccination in Children Aged 5-11 Years.
Vaccines (Basel);
10(11)2022 Nov 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36423049